Illness representations, coping and anxiety among men with localized prostate cancer over an 18-months period: A parallel vs. level-contrast mediation approach.
active surveillance
anxiety
common sense model
consequences
coping
curative treatment
illness representations
mediation
oncology
prostate cancer
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
09
08
2021
received:
02
03
2021
accepted:
11
08
2021
pubmed:
2
9
2021
medline:
20
4
2022
entrez:
1
9
2021
Statut:
ppublish
Résumé
Men diagnosed with localized prostate cancer (lPCa) are confronted with the decision for a treatment strategy, potentially experiencing treatment side effects and psychological distress. The Common Sense Model proposes that coping with such challenges is related to illness representations: Beliefs regarding consequences, coherence, timeline, and controllability of the illness. We analyzed the interplay of illness representations, coping and anxiety over an 18-month period among men with lPCa undergoing different treatment options (Active Surveillance, curative treatment). In this longitudinal study, 183 men (age M = 66.83) answered a questionnaire before starting treatment, and 6, 12, and 18 months later. We analyzed time trajectories with growth curve modeling and conducted mediation analyses to evaluate the influence of coping on the association of illness representations and anxiety. Using a novel methodological approach, we compared a classic parallel mediation model with a level-contrast approach for the correlated mediators problem- and emotion-focused coping. Independent of treatment (b = 1.31, p = 0.200) men reported an elevated level of anxiety after diagnosis which declined considerably within the following 6 months (b = -1.87, p = 0.009). The perceived seriousness of consequences was significantly associated with greater anxiety, at baseline (β = 0.471) and over time (all β ≥ 0.204). This association was mediated by coping: Using more emotion-than problem-focused coping was associated with higher anxiety. Receiving a lPCa diagnosis is associated with a phase of increased anxiety. In order to reduce anxiety, information provision should be accompanied by developing concrete action plans to enable problem-focused coping strategies.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
227-237Informations de copyright
© 2021 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Références
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J cancer. 2019;144(8):1941-1953.
Neal DE, Metcalfe C, Donovan JL, et al. Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received. Eur Urol. 2020;77(3):320-330.
Mottet N, Cornford P, RCNvd B, et al. EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer. Arnhem: EAU Guidelines Office; 2020. Report No.: 978-94-92671-07-3.
Filson CP, Marks LS, Litwin MS. Expectant Management for Men with Early Stage Prostate Cancer. California: A Cancer Journal for Clinicians. 2015.
Hamdy FC, Donovan JL, Lane JA, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N. Engl J Med. 2016;375(15):1415-1424.
Wilt TJ, Jones KM, Barry MJ, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N. Engl J Med. 2017;377(2):132-142.
Adam S, Koch-Gallenkamp L, Bertram H, et al. Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study. Eur J Canc Care. 2019:e13076.
Lardas M, Liew M, van den Bergh R, et al. Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review. Eur Urol. 2017;72:869-885.
Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2-3):343-351.
Esser P, Mehnert-Theuerkauf A, Friedrich M, et al. Risk and associated factors of depression and anxiety in men with prostate cancer: results from a German multicenter study. Psycho-oncology. 2020;29:1604-1612.
Lintz K, Moynihan C, Steginga S, et al. Prostate cancer patients' support and psychological care needs: survey from a non-surgical oncology clinic. Psycho-oncology. 2003;12(8):769-783.
Gotze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support care cancer: official J Multinatl Assoc Support Care Cancer. 2020;28(1):211-220.
Watts S, Leydon G, Birch B, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ open. 2014;4(3):e003901. https://doi.org/10.1136/bmjopen-2013-003901
Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or Radiotherapy for prostate cancer. N. Engl J Med. 2016;375(15):1425-1437.
Venderbos LDF, Aluwini S, Roobol MJ, et al. Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer. Qual life Res: Int J Qual life aspects Treat care rehabilitation. 2017;26(6):1635-1645.
Chambers SK, Ng SK, Baade P, et al. Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psycho-oncology. 2017;26(10):1576-1585.
Shrout PE, Stadler G, Lane SP, et al. Initial elevation bias in subjective reports. Proc Natl Acad Sci U. S. A. 2018;115(1):E15-E23.
Leventhal H, Nerenz DR, Steele DJ. Illness representation and coping with health threats. In: Baum A, Taylor SE, Singer JE, eds. Handbook of Psychology and Health. Vol 4. Hillsdale: Lawrence Erlbaum Associates; 1984:219-252.
Hagger MS, Koch S, Chatzisarantis NLD, Orbell S. The common sense model of self-regulation: meta-analysis and test of a process model. Psychol Bull. 2017;143(11):1117-1154.
Richardson EM, Schuez N, Sanderson K, Scott JL, Schuez B. Illness representations, coping, and illness outcomes in people with cancer: a systematic review and meta-analysis. Psycho-oncology. 2017;26(6):724-737.
Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ. A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol Health. 2015;30(11):1361-1385.
Dempster M, Howell D, McCorry NK. Illness perceptions and coping in physical health conditions: a meta-analysis. J psychosomatic Res. 2015;79(6):506-513.
Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer Publishing Company LLC; 1984.
Mickevičienė A, Vanagas G, Jievaltas M, Ulys A. Does illness perception explain quality of life of patients with prostate cancer? Medicina (Kaunas). 2013;49(5):235-241.
Traeger L, Penedo FJ, Gonzalez JS, et al. Illness perceptions and emotional well-being in men treated for localized prostate cancer. J psychosomatic Res. 2009;67(5):389-397.
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF). Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 5.1; 2019. Report No.: 043/022OL.
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J psychosomatic Res. 2006;60(6):631-637.
Carver CS. You want to measure coping but your protocol's too long: consider the brief cope. Int J Behav Med. 1997;4(1):92-100.
Knoll N, Rieckmann N, Schwarzer R. Coping as a mediator between personality and stress outcomes: a longitudinal study with cataract surgery patients. Eur J Pers. 2005;19(3):229-247.
Hagger MS, Orbell S. A meta-analytic review of the common-sense model of illness representations. Psychol Health. 2003;18(2):141-184.
Kendel F, Otto I, Engler J, Schrader M, Holmberg C. [Living with localized prostate cancer - decision-making and coping with the illness]. Psychother Psychosom Med Psychol. 2018;68(11):462-469.
Roth AJ, Rosenfeld B, Kornblith AB, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer. 2003;97(11):2910-2918.
Roth AJ, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the memorial anxiety scale for prostate cancer (MAX-PC). Psychosomatics. 2006;47(4):340-347.
Iida M, Seidman G, Shrout PE. Models of interdependent individuals versus dyadic processes in relationship research. J Soc Pers Relat. 2017;35(1):59-88.
Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis Second Edition A Regression-Based Approach. In: Little TD, ed. New York: Guilford Press; 2017.
Joshy G, Thandrayen J, Koczwara B, et al. Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer. BMC Med. 2020;18(1):372.
Rivera A, Scholar J. Traditional masculinity: a review of toxicity rooted in social norms and gender socialization. ANS Adv Nurs Sci. 2020;43(1):E1-E10.
Leventhal EA, Crouch M. Are there differences in perceptions of illness across the lifespan? In: Weinman JA, eds. Perceptions of health and illness: Current research and applications. Amsterdam: Harwood Academic Publishers; 1997:77-102.
Graham L, Dempster M, McCorry NK, Donnelly M, Johnston BT. Change in psychological distress in longer-term oesophageal cancer carers: are clusters of illness perception change a useful determinant? Psycho-Oncology. 2016;25(6):663-669.
van Broekhoven ME, de Rooij BH, Pijnenborg JM, et al. Illness perceptions and changes in lifestyle following a gynecological cancer diagnosis: a longitudinal analysis. Gynecol Oncol. 2017;145(2):310-318.
Kendel F, Otto I, Hilger C. Illness representations among men with prostate cancer; open science framework (OSF); 2021. doi:10.17605/OSF.IO/YJ5CA